Jump to main content
Jump to site search

Issue 35, 2019
Previous Article Next Article

In situ biosynthesized gold nanoclusters inhibiting cancer development via the PI3K–AKT signaling pathway

Author affiliations

Abstract

Nanomaterials have made great breakthroughs in drug delivery. However, in previous studies, nanomaterials have been mostly used as vehicles to transport drugs into tumors. Herein, we first found that the in situ biosynthesized gold nanoparticles (Au NCs) can inhibit cancer development via the inhibition of some signaling pathways. Classical cell phenotypic assay tests and orthotropic liver tumor model both showed that the in situ biosynthesized Au NCs could inhibit tumor development. With the help of the RNA-seq analysis, we found that the in situ biosynthesized Au NCs could significantly inhibit the PI3K–AKT signaling pathway, thus effectively impeding tumor development. This facile and effective tumor targeting theranostics in vivo can effectively cure cancers in future clinical applications.

Graphical abstract: In situ biosynthesized gold nanoclusters inhibiting cancer development via the PI3K–AKT signaling pathway

Back to tab navigation

Supplementary files

Publication details

The article was received on 29 May 2019, accepted on 24 Jul 2019 and first published on 25 Jul 2019


Article type: Paper
DOI: 10.1039/C9TB01070J
J. Mater. Chem. B, 2019,7, 5336-5344

  •   Request permissions

    In situ biosynthesized gold nanoclusters inhibiting cancer development via the PI3K–AKT signaling pathway

    M. Wang, Z. Yu, H. Feng, J. Wang, L. Wang, Y. Zhang, L. Yin, Y. Du, H. Jiang, X. Wang and J. Zhou, J. Mater. Chem. B, 2019, 7, 5336
    DOI: 10.1039/C9TB01070J

Search articles by author

Spotlight

Advertisements